» Articles » PMID: 9468488

Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Mar 21
PMID 9468488
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue factor (TF) pathway inhibitor (TFPI) regulates factor X activation through the sequential inhibition of factor Xa and the VIIa.TF complex. Factor Xa formation was studied in a purified, reconstituted system, at plasma concentrations of factor X and TFPI, saturating concentrations of factor VIIa, and increasing concentrations of TF reconstituted into phosphatidylcholine:phosphatidylserine membranes (TF/PCPS) or PC membranes (TF/PC). The initial rate of factor Xa formation was equivalent in the presence or absence of 2.4 nM TFPI. However, reaction extent was small (<20%) relative to that observed in the absence of TFPI, implying the rapid inhibition of VIIa.TF during factor X activation. Initiation of factor Xa formation using increasing concentrations of TF/PCPS or TF/PC in the presence of TFPI yielded families of progress curves where both initial rate and reaction extent were linearly proportional to the concentration of VIIa.TF. These observations were consistent with a kinetic model in which the rate-limiting step represents the initial inhibition of newly formed factor Xa. Numerical analyses of progress curves yielded a rate constant for inhibition of VIIa.TF by Xa.TFPI (>10(8) M-1.s-1) that was substantially greater than the value (7.34 +/- 0.8 x 10(6) M-1.s-1) directly measured. Thus, VIIa.TF is inhibited at near diffusion-limited rates by Xa.TFPI formed during catalysis which cannot be explained by studies of the isolated reaction. We propose that the predominant inhibitory pathway during factor X activation may involve the initial inhibition of factor Xa either bound to or in the near vicinity of VIIa.TF on the membrane surface. As a result, VIIa.TF inhibition is unexpectedly rapid, and the concentration of active factor Xa that escapes regulation is linearly dependent on the availability of TF.

Citing Articles

Characterization of the procoagulant phenotype of amniotic fluid across gestation in rhesus macaques and humans.

Yang C, Shorey-Kendrick L, Puy C, Benson A, Wilmarth P, Reddy A Res Pract Thromb Haemost. 2025; 9(1):102676.

PMID: 40070370 PMC: 11894163. DOI: 10.1016/j.rpth.2024.102676.


A new look at TFPI inhibition of factor X activation.

Santiago F, Kaur A, Bride S, Monroe D, Leiderman K, Sindi S PLoS Comput Biol. 2024; 20(11):e1012509.

PMID: 39546494 PMC: 11567595. DOI: 10.1371/journal.pcbi.1012509.


SARS-CoV-2 Spike Proteins and Cell-Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for the Pathogenesis of COVID-19....

Bhargavan B, Kanmogne G Int J Mol Sci. 2023; 24(16).

PMID: 37628764 PMC: 10454213. DOI: 10.3390/ijms241612585.


A Review of Quantitative Systems Pharmacology Models of the Coagulation Cascade: Opportunities for Improved Usability.

Chung D, Bakshi S, van der Graaf P Pharmaceutics. 2023; 15(3).

PMID: 36986779 PMC: 10054658. DOI: 10.3390/pharmaceutics15030918.


The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans.

Hassan N, Efing J, Kiesel L, Bendas G, Gotte M Cancers (Basel). 2023; 15(5).

PMID: 36900315 PMC: 10001432. DOI: 10.3390/cancers15051524.